{"id":"W4410140459","doi":"10.1182/bloodadvances.2025016229","title":"Pivotal results of SELECT-MDS-1 phase 3 study of tamibarotene with azacitidine in newly diagnosed higher-risk MDS","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre","funders":"Genentech; Swedish Orphan Biovitrum; Servier; Astellas Pharma; Incyte; bluebird bio; Agios Pharmaceuticals; Astex Pharmaceuticals; Celgene; Gilead Sciences; Syndax Pharmaceuticals; BeiGene; Daiichi Sankyo Europe; Sanofi; Pfizer; Amgen","keywords":"Azacitidine; Placebo; Medicine; Internal medicine; Oncology; Clinical endpoint; Gastroenterology; Randomized controlled trial; Biology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004458062,0.0002475356,0.0007853888,0.0004622992,0.00005044571,0.000008028952,0.0002487806,0.00008623138,0.00002466937],"category_scores_gemma":[0.000593377,0.0001875575,0.00006136217,0.001609972,0.0001972298,0.0001695953,0.00009367938,0.0004504148,0.000002275602],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008656262,"about_ca_system_score_gemma":0.0004387225,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001303332,"about_ca_topic_score_gemma":0.0009124622,"domain_scores_codex":[0.997604,0.0001758114,0.0007258217,0.0004996983,0.0005921891,0.0004025248],"domain_scores_gemma":[0.998213,0.000524895,0.0002831172,0.0005545951,0.000312018,0.0001123852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.04125202,0.04042283,0.7114944,0.001579211,0.001985939,0.002412215,0.003952515,0.001372166,0.110582,0.0002220216,0.00167726,0.08304731],"study_design_scores_gemma":[0.2892015,0.03585752,0.3103132,0.001798862,0.001188935,0.00004008802,0.00492862,0.0003366825,0.35001,0.0002055482,0.005523169,0.0005957938],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935336,0.002017837,0.00004739827,0.0003500119,0.00006059943,0.001379573,0.00009234659,0.00004533718,0.002473268],"genre_scores_gemma":[0.9962615,0.000661055,0.00144997,0.00004604742,0.00007440606,0.0001069985,0.00003169815,0.00002546425,0.001342871],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4011812,"threshold_uncertainty_score":0.7648373,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01056674117436585,"score_gpt":0.3171685288221179,"score_spread":0.306601787647752,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}